본문으로 건너뛰기
← 뒤로

Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.

1/5 보강
International urology and nephrology 📖 저널 OA 12.4% 2022: 0/2 OA 2023: 0/1 OA 2024: 0/1 OA 2025: 4/33 OA 2026: 7/49 OA 2022~2026 2025 Vol.57(11) p. 3481-3497
Retraction 확인
출처

Zhao S, Liu Y, Wang H, Wang J, Zhang J, Liu Y

📝 환자 설명용 한 줄

Prostate cancer (PCa) is a leading cause of cancer-related morbidity and mortality in men worldwide.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Zhao S, Liu Y, et al. (2025). Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.. International urology and nephrology, 57(11), 3481-3497. https://doi.org/10.1007/s11255-025-04497-z
MLA Zhao S, et al.. "Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.." International urology and nephrology, vol. 57, no. 11, 2025, pp. 3481-3497.
PMID 40266504 ↗

Abstract

Prostate cancer (PCa) is a leading cause of cancer-related morbidity and mortality in men worldwide. Despite advancements in diagnosis and treatment, challenges such as late-stage detection, therapeutic resistance, and the complexity of castration-resistant prostate cancer (CRPC) persist. Long non-coding RNAs (LncRNAs) play critical roles in PCa progression through epigenetic regulation, transcriptional and post-transcriptional modulation, and immune response regulation. This review highlights the molecular mechanisms by which LncRNAs influence PCa development, treatment resistance, and immune regulation, emphasizing their potential as biomarkers and therapeutic targets. We also discuss future research directions to advance precision medicine in PCa.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반